Literature DB >> 18433400

Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient.

Pilar Martinez Montiel, Jose Antonio Solis, Juan Antonio Chirinos, Begoń a Casis, Fernando Sánchez, Sarbelio Rodríguez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18433400     DOI： 10.1111/j.1478-3231.2007.01665.x

Source DB:  PubMed          Journal:  Liver Int        ISSN： 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  18 in total

1.  A practical approach to screening psoriasis patients for therapy with biologic agents.

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

2.  A practical approach to monitoring patients on biological agents for the treatment of psoriasis.

Authors:  Jason J Emer; Amylynne Frankel; Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

3.  Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression.

Authors:  Seper Dezfoli; Gil Y Melmed
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-08

Review 4.  Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.

Authors:  Shunsuke Mori; Shigetoshi Fujiyama
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

5.  Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.

Authors:  Gregory A Yanik; Shin Mineishi; John E Levine; Carrie L Kitko; Eric S White; Mark T Vander Lugt; Andrew C Harris; Thomas Braun; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-10       Impact factor: 5.742

6.  Involvement of the liver in rheumatic diseases.

Authors:  Hiromasa Ohira; Kazumichi Abe; Atsushi Takahashi
Journal:  Clin J Gastroenterol       Date:  2011-11-26

7.  Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines?

Authors:  Jinoos Yazdany; Leonard Calabrese
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

Review 8.  Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.

Authors:  Pilar López-Serrano; Jose Lázaro Pérez-Calle; Maria Dolores Sánchez-Tembleque
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 9.  Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?

Authors:  Jason S Reich; Francis A Farraye; Sharmeel K Wasan
Journal:  Dig Dis Sci       Date:  2016-04-09       Impact factor: 3.199

Review 10.  Effect of etanercept and entecavil in a patient with rheumatoid arthritis who is a hepatitis B carrier: a review of the literature.

Authors:  Takeshi Kuroda; Yoko Wada; Daisuke Kobayashi; Hiroe Sato; Syuichi Murakami; Masaaki Nakano; Ichiei Narita
Journal:  Rheumatol Int       Date:  2010-01-09       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.